Influence of the APOE genotypes in some atherosclerotic risk factors;Influência dos polimorfismos da APOE em alguns factores de risco de aterosclerose

Acta Medica Portuguesa

Volumn 21, Issue 5, 2008, Pages 433-440

  Carmo Martins, Maria ^a   Lima Faleiro, Luís ^b   Rodrigues, Maria Odete ^a   Albergaria, Isabel ^a   Fonseca, Aidil ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Instituto Portugues DG   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BODY MASS; DIASTOLIC BLOOD PRESSURE; GENOTYPE; HUMAN; HYPERTENSION; NORMAL HUMAN; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 77749330699     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. GREGG RE, BREWER HB Jr: The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B containing lipoproteins in humans. Clin Chem 1988;34:B28-B32
2. KWIJTT P, MAAGDENBERG AM, FRANTS RR, HAWEKES LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Human Mut 1994;4:178-94
3. MILLER SA, DYKES DD, POLESKY HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;6:1215.
4. HIXSON JE, VERNIER DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8
5. Sociedade Portuguesa de Aterosclerose: Recomendações Portuguesas para a prevenção primária e secundária da aterosclerose. Lisboa SPA 2000
6. World Health Organization: International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999;17:151-183
7. European Society of Hypertension - European Society of Cardiology: Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
8. RODRIGUES MO, FONSECA A, DIAS CM, ALBERGARIA I, MARTINS G, MARTINS MC: APOE genotypes na d dyslipidemias in a sample of the Portuguese population Clin Chem Lab Med 2005;43(9):907-912
9. SCHIELE F, DE BACQUER D, VINCENT-VIRY M et al: Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000;152:475-488
10. LAHLALI-KACEMI N, BAMON Y, GUEDIRA A et al : Polymorphism de l'apolipoprotein E dans une population Morocaine: fréquence allélique et relation avec les paramètres lipidiques plasmatiques. Ann Biol Clin 2002;60:73-8
11. MAHLEY RW, RALL SC JR: Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR. Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. NewYork: McGraw-Hill 1995:1953-80
12. DALLONGEVILLE J, LUSSIER-CACAN S, DAVIGNON J: Modulation of plasma triglycerides levels by apoE phenotype: a meta-analysis. J Lipid Res 1992;33:447-454
13. LENZEN HJ, ASSMANN G, BUCHWAISKY R, SCHULTE H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986;32:778-781
14. STENGARD JH, ZERBE KE, PEKKANEN J, EHNHOLM C. NISSINEN A, SING CF: Apolipoprotein E polymorphism predicts death from Coronary Hearth Disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9
15. STENGARD JH, PEKKANEN J, EHNHOLM C. NISSINEN A, SING CF: Genotypes with the apolipoprotein ε4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65-84 years. Hum Genet 1996;97:677-684
16. WILSON PWF, MYERS RH, LARSON MG, ORDOVAS JM, WOLF PA, SCHAEFER EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-71
17. SONG Y, STAMPFER MJ, LIN S: Meta-analysis: Apolipoprotein E genotypes and risk for Coronary Heart Disease. Ann Inter Med 2004;141:137-147
18. SASS C, HERBETH B, ZANNAD F, SIEST G, VISVIKIS S: Blood pressure and apolipoprotein E genotypes in the Stanislas family study. In Biologie Prospective, IXe Colloque de Pont à Mousson. Eurobiologie, 29 Septembre-3 Octobre 1996. Galteau MM, Delwaide P, Siest G, Henny J. Eds. John Libbey Eurotext Publ 1997,171-4
19. DE KNIJFF P, BOOMSMA DI, FESKENS EJM et al: Apolipoprotein E phenotype and blood pressure. Lancet 1994;343:1234-5
20. GUERRA A, REGO C, CASTRO EMB, SEIXAS S, ROCHA J: Influence of apolipoprotein E polymorphism on cardiovascular risk factors in obese children. Ann Nutr Metab 2003;47:49-54
21. SRINIVASAN SR, EHNHOLM C, ELKASABANY A, BERENSON GS: Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Hearth Study. Metabolism 2001;50:696-702.
22. UUSITUPA MIJ, KARHUNEN L, RISSANEN A et al: Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am J Clin Nutr 1996;64:131-6
23. ELOSNA R, DEMISSIE S, CUPPLES LA et al : Obesity modulates the association among ApoE genotype, insulin and glucose in men. Obes Res 2003;11:1502-8
24. DJOUSSÉ L, MEYERS RH, PROVINCE MA et al : Influence of apolipoprotein E, smoking and alcohol intake in carotid atherosclerosis: National Heart, Lung and Blood Institute Family Heart Study. Stroke 2002;33:1357-61
25. KEAVNEY B, PARISH S, PALMER A et al: Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotype. The Lancet 2003;361:396-8